Masimo Corporation Company Profile (NASDAQ:MASI)

About Masimo Corporation (NASDAQ:MASI)

Masimo Corporation logoMasimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company's business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive monitoring of blood constituents with an optical signature, optical organ oximetry monitoring, electrical, brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. In addition, the Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor, and the Radius-7 wearable wireless patient monitor. It offers Patient SafetyNet remote patient surveillance monitoring system, which allows patients to be monitored through a personal computer-based monitor or by care providers through their pagers, voice-over-Internet Protocol (IP) phones or smartphones.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:MASI
  • CUSIP: 57479510
  • Web: www.masimo.com
Capitalization:
  • Market Cap: $4.45491 billion
  • Outstanding Shares: 51,940,000
Average Prices:
  • 50 Day Moving Avg: $85.78
  • 200 Day Moving Avg: $90.95
  • 52 Week Range: $53.78 - $104.71
P/E:
  • Trailing P/E Ratio: 13.99
  • Foreward P/E Ratio: 33.90
  • P/E Growth: 1.52
Sales & Book Value:
  • Annual Revenue: $730.06 million
  • Price / Sales: 6.10
  • Book Value: $13.66 per share
  • Price / Book: 6.28
Profitability:
  • EBIDTA: $182.11 million
  • Net Margins: 45.90%
  • Return on Equity: 23.45%
  • Return on Assets: 16.22%
Debt:
  • Current Ratio: 3.89%
  • Quick Ratio: 3.29%
Misc:
  • Average Volume: 514,150 shs.
  • Beta: 0.84
  • Short Ratio: 5.21
 

Frequently Asked Questions for Masimo Corporation (NASDAQ:MASI)

What is Masimo Corporation's stock symbol?

Masimo Corporation trades on the NASDAQ under the ticker symbol "MASI."

How were Masimo Corporation's earnings last quarter?

Masimo Corporation (NASDAQ:MASI) posted its quarterly earnings results on Wednesday, August, 2nd. The company reported $0.83 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.71 by $0.12. The business had revenue of $192.90 million for the quarter, compared to the consensus estimate of $189.03 million. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. Masimo Corporation's revenue for the quarter was up 11.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.57 earnings per share. View Masimo Corporation's Earnings History.

When will Masimo Corporation make its next earnings announcement?

Masimo Corporation is scheduled to release their next quarterly earnings announcement on Wednesday, November, 1st 2017. View Earnings Estimates for Masimo Corporation.

What guidance has Masimo Corporation issued on next quarter's earnings?

Masimo Corporation issued an update on its FY17 earnings guidance on Wednesday, August, 2nd. The company provided EPS guidance of $2.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.60. The company issued revenue guidance of $769 million, compared to the consensus revenue estimate of $759.39 million.

Where is Masimo Corporation's stock going? Where will Masimo Corporation's stock price be in 2017?

7 equities research analysts have issued 12-month price objectives for Masimo Corporation's stock. Their predictions range from $60.00 to $112.00. On average, they expect Masimo Corporation's share price to reach $97.00 in the next twelve months. View Analyst Ratings for Masimo Corporation.

Who are some of Masimo Corporation's key competitors?

Who are Masimo Corporation's key executives?

Masimo Corporation's management team includes the folowing people:

  • Joseph E. Kiani, Chairman of the Board, Chief Executive Officer
  • Mark P. de Raad, Chief Financial Officer, Executive Vice President - Finance
  • Jon Coleman, President - Worldwide Sales, Professional Services and Medical Affairs
  • Rick Fishel, President - Worldwide OEM Business & Strategic Development
  • Anand Sampath, Chief Operating Officer
  • Yongsam Lee, Executive Vice President, Chief Information Officer
  • Tom McClenahan, Executive Vice President, General Counsel, Corporate Secretary
  • Steven J. Barker M.D., Ph.D., Director
  • Sanford Fitch, Independent Director
  • Thomas Harkin, Independent Director

Who owns Masimo Corporation stock?

Masimo Corporation's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (15.24%), Vanguard Group Inc. (9.50%), Acadian Asset Management LLC (3.50%), State Street Corp (2.98%), Arrowstreet Capital Limited Partnership (2.14%) and Robeco Institutional Asset Management B.V. (2.11%). Company insiders that own Masimo Corporation stock include Anand Sampath, Joe E Kiani, Jon Coleman, Paul Jansen, Raad Mark De, Ramshorst David J Van, Rick Fishel, Sanford Fitch, Thomas Samuel Mcclenahan and Yongsam Lee. View Institutional Ownership Trends for Masimo Corporation.

Who sold Masimo Corporation stock? Who is selling Masimo Corporation stock?

Masimo Corporation's stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Numeric Investors LLC, Westfield Capital Management Co. LP, BTIM Corp., Goldman Sachs Group Inc., Canada Pension Plan Investment Board, Rothschild Asset Management Inc. and Schroder Investment Management Group. Company insiders that have sold Masimo Corporation stock in the last year include Anand Sampath, Joe E Kiani, Jon Coleman, Paul Jansen, Raad Mark De, Ramshorst David J Van, Rick Fishel, Sanford Fitch, Thomas Samuel Mcclenahan and Yongsam Lee. View Insider Buying and Selling for Masimo Corporation.

Who bought Masimo Corporation stock? Who is buying Masimo Corporation stock?

Masimo Corporation's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Koch Industries Inc., Acadian Asset Management LLC, JPMorgan Chase & Co., Vanguard Group Inc., Capital Fund Management S.A., Robeco Institutional Asset Management B.V. and Russell Investments Group Ltd.. View Insider Buying and Selling for Masimo Corporation.

How do I buy Masimo Corporation stock?

Shares of Masimo Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Masimo Corporation's stock price today?

One share of Masimo Corporation stock can currently be purchased for approximately $85.77.


MarketBeat Community Rating for Masimo Corporation (NASDAQ MASI)
Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  187 (Vote Outperform)
Underperform Votes:  144 (Vote Underperform)
Total Votes:  331
MarketBeat's community ratings are surveys of what our community members think about Masimo Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Masimo Corporation (NASDAQ:MASI) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $97.00 (13.09% upside)

Analysts' Ratings History for Masimo Corporation (NASDAQ:MASI)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/14/2017BTIG ResearchUpgradeNeutral -> Buy$100.00MediumView Rating Details
8/3/2017Stifel NicolausReiterated RatingBuy$105.00 -> $108.00HighView Rating Details
7/19/2017Roth CapitalBoost Price TargetBuy$96.00 -> $105.00LowView Rating Details
5/22/2017WedbushReiterated RatingOutperform$112.00LowView Rating Details
3/16/2017Piper Jaffray CompaniesDowngradeOverweight -> NeutralHighView Rating Details
2/13/2017Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
2/13/2017Citigroup Inc.DowngradeMarket Perform$60.00N/AView Rating Details
(Data available from 9/22/2015 forward)

Earnings

Earnings History for Masimo Corporation (NASDAQ:MASI)
Earnings by Quarter for Masimo Corporation (NASDAQ:MASI)
Earnings History by Quarter for Masimo Corporation (NASDAQ MASI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2017N/AView Earnings Details
8/2/2017Q2 2017$0.71$0.83$189.03 million$192.90 millionViewListenView Earnings Details
5/3/2017Q1 2017$0.60$0.82$184.14 million$186.30 millionViewListenView Earnings Details
2/14/2017Q416$0.52$0.51$180.48 million$183.20 millionViewListenView Earnings Details
11/2/2016Q316$0.42$0.52$165.51 million$167.60 millionViewListenView Earnings Details
8/3/2016Q216$0.41$0.57$166.02 million$172.64 millionViewListenView Earnings Details
5/4/2016Q116$0.43$0.53$165.25 million$171.20 millionViewListenView Earnings Details
2/23/2016Q415$0.39$0.15$164.25 million$167.30 millionViewListenView Earnings Details
11/5/2015Q315$0.31$0.36$149.31 million$152.60 millionViewListenView Earnings Details
8/4/2015Q215$0.32$0.43$147.93 million$155.73 millionViewListenView Earnings Details
5/6/2015Q115$0.35$0.41$151.00 million$154.54 millionViewListenView Earnings Details
2/17/2015Q414$0.37$0.40$159.45 million$161.80 millionViewListenView Earnings Details
10/29/2014Q314$0.25$0.27$144.20 million$144.10 millionViewListenView Earnings Details
8/7/2014Q214$0.29$0.27$145.76 million$140.92 millionViewListenView Earnings Details
4/30/2014Q114$0.29$0.39$144.01 million$139.80 millionViewListenView Earnings Details
2/13/2014Q413$0.31$0.31$148.25 million$134.70 millionViewListenView Earnings Details
10/30/2013Q313$0.26$0.27$132.47 million$131.40 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.28$0.30$136.36 million$137.42 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.28$0.28$134.46 million$135.90 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.29$0.26$129.09 million$132.20 millionViewListenView Earnings Details
11/1/2012Q312$0.26$0.26$120.99 million$112.10 millionViewN/AView Earnings Details
8/1/2012$0.28$0.27ViewN/AView Earnings Details
5/2/2012$0.28$0.27ViewN/AView Earnings Details
2/14/2012$0.23$0.23ViewN/AView Earnings Details
10/25/2011$0.27$0.24ViewN/AView Earnings Details
8/9/2011$0.28$0.28ViewN/AView Earnings Details
5/3/2011$0.30$0.30ViewN/AView Earnings Details
2/15/2011$0.26$0.29ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Masimo Corporation (NASDAQ:MASI)
2017 EPS Consensus Estimate: $2.30
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.59$0.60$0.60
Q2 20172$0.54$0.55$0.55
Q3 20172$0.53$0.53$0.53
Q4 20172$0.62$0.64$0.63
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Masimo Corporation (NASDAQ:MASI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Masimo Corporation (NASDAQ:MASI)
Insider Ownership Percentage: 16.60%
Institutional Ownership Percentage: 83.21%
Insider Trades by Quarter for Masimo Corporation (NASDAQ:MASI)
Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)
Insider Trades by Quarter for Masimo Corporation (NASDAQ:MASI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/17/2017Sanford FitchDirectorSell11,000$87.25$959,750.00View SEC Filing  
7/20/2017Jon ColemanInsiderSell25,000$97.50$2,437,500.00View SEC Filing  
7/14/2017Rick FishelInsiderSell15,000$94.85$1,422,750.00View SEC Filing  
7/13/2017Sanford FitchDirectorSell6,000$91.89$551,340.00View SEC Filing  
7/11/2017Anand SampathCOOSell40,000$92.00$3,680,000.00View SEC Filing  
7/11/2017Rick FishelInsiderSell15,000$92.85$1,392,750.00View SEC Filing  
6/29/2017Sanford FitchDirectorSell14,000$92.06$1,288,840.00View SEC Filing  
5/1/2017Joe E KianiCEOSell145,841$102.37$14,929,743.17View SEC Filing  
4/28/2017Thomas Samuel McclenahanEVPSell8,000$102.75$822,000.00View SEC Filing  
4/26/2017Joe E KianiCEOSell154,159$99.70$15,369,652.30View SEC Filing  
4/25/2017Joe E KianiCEOSell13,201$101.00$1,333,301.00View SEC Filing  
4/25/2017Jon ColemanInsiderSell50,000$100.00$5,000,000.00View SEC Filing  
4/25/2017Yongsam LeeEVPSell10,000$100.00$1,000,000.00View SEC Filing  
4/24/2017Joe E KianiCEOSell100,000$99.00$9,900,000.00View SEC Filing  
4/24/2017Thomas Samuel McclenahanEVPSell10,000$98.75$987,500.00View SEC Filing  
4/20/2017Thomas Samuel McclenahanEVPSell10,000$95.75$957,500.00View SEC Filing  
4/19/2017Yongsam LeeEVPSell10,000$95.00$950,000.00View SEC Filing  
4/4/2017Raad Mark DeCFOSell48,000$93.25$4,476,000.00View SEC Filing  
3/22/2017Sanford FitchDirectorSell3,000$93.23$279,690.00View SEC Filing  
3/10/2017Paul JansenEVPSell55,611$94.47$5,253,571.17View SEC Filing  
3/9/2017Ramshorst David J VanInsiderSell7,500$94.20$706,500.00View SEC Filing  
2/23/2017Raad Mark DeCFOSell30,000$86.25$2,587,500.00View SEC Filing  
2/17/2017Raad Mark DeCFOSell45,000$80.00$3,600,000.00View SEC Filing  
2/16/2017Joe E KianiCEOSell300,000$80.04$24,012,000.00View SEC Filing  
2/3/2017Jon ColemanInsiderSell6,000$75.00$450,000.00View SEC Filing  
2/3/2017Raad Mark DeCFOSell15,000$75.00$1,125,000.00View SEC Filing  
1/27/2017Jon ColemanInsiderSell5,800$72.50$420,500.00View SEC Filing  
1/27/2017Raad Mark DeCFOSell15,000$72.50$1,087,500.00View SEC Filing  
1/20/2017Jon ColemanInsiderSell200$72.50$14,500.00View SEC Filing  
1/13/2017Yongsam LeeEVPSell10,000$72.00$720,000.00View SEC Filing  
1/10/2017Jon ColemanInsiderSell6,000$70.00$420,000.00View SEC Filing  
1/10/2017Raad Mark DeCFOSell15,000$70.00$1,050,000.00View SEC Filing  
1/10/2017Yongsam LeeEVPSell10,000$70.00$700,000.00View SEC Filing  
1/9/2017Paul JansenEVPSell17,945$68.88$1,236,051.60View SEC Filing  
1/3/2017Ramshorst David J VanInsiderSell4,000$67.20$268,800.00View SEC Filing  
12/27/2016Paul JansenEVPSell2,055$68.88$141,548.40View SEC Filing  
12/21/2016Jon ColemanInsiderSell4,000$67.50$270,000.00View SEC Filing  
12/16/2016Thomas Samuel McclenahanEVPSell10,000$66.00$660,000.00View SEC Filing  
12/8/2016Paul JansenEVPSell10,000$63.88$638,800.00View SEC Filing  
12/7/2016Thomas Samuel McclenahanEVPSell2,293$63.00$144,459.00View SEC Filing  
12/6/2016Joe E KianiCEOSell52,859$62.03$3,278,843.77View SEC Filing  
12/6/2016Thomas Samuel McclenahanEVPSell4,000$63.00$252,000.00View SEC Filing  
12/1/2016Joe E KianiCEOSell36,119$62.06$2,241,545.14View SEC Filing  
11/29/2016Joe E KianiCEOSell104,870$62.27$6,530,254.90View SEC Filing  
11/23/2016Joe E KianiCEOSell85,771$62.06$5,322,948.26View SEC Filing  
11/22/2016Joe E KianiCEOSell869$62.00$53,878.00View SEC Filing  
11/21/2016Joe E KianiCEOSell30,462$62.04$1,889,862.48View SEC Filing  
11/18/2016Joe E KianiCEOSell20,381$62.02$1,264,029.62View SEC Filing  
11/1/2016Anand SampathCOOSell65,000$55.04$3,577,600.00View SEC Filing  
10/31/2016Anand SampathCOOSell51,345$55.05$2,826,542.25View SEC Filing  
10/19/2016Sanford FitchDirectorSell2,000$59.05$118,100.00View SEC Filing  
10/10/2016Joe E KianiCEOSell84,617$60.26$5,099,020.42View SEC Filing  
10/10/2016Yongsam LeeEVPSell30,000$60.50$1,815,000.00View SEC Filing  
10/5/2016Sanford FitchDirectorSell2,000$59.58$119,160.00View SEC Filing  
10/4/2016Joe E KianiCEOSell4,300$60.07$258,301.00View SEC Filing  
10/3/2016Joe E KianiCEOSell2,200$60.00$132,000.00View SEC Filing  
9/30/2016Thomas Samuel McclenahanEVPSell10,000$59.00$590,000.00View SEC Filing  
9/27/2016Joe E KianiCEOSell4,464$60.01$267,884.64View SEC Filing  
9/22/2016Joe E KianiCEOSell49,484$60.18$2,977,947.12View SEC Filing  
9/21/2016Sanford FitchDirectorSell2,000$59.41$118,820.00View SEC Filing  
9/20/2016Joe E KianiCEOSell400$60.16$24,064.00View SEC Filing  
9/19/2016Joe E KianiCEOSell999$60.03$59,969.97View SEC Filing  
9/7/2016Joe E KianiCEOSell33,536$60.00$2,012,160.00View SEC Filing  
9/7/2016Jon ColemanInsiderSell6,000$60.00$360,000.00View SEC Filing  
9/7/2016Sanford FitchDirectorSell2,000$59.81$119,620.00View SEC Filing  
8/17/2016Sanford FitchDirectorSell2,000$58.11$116,220.00View SEC Filing  
8/4/2016Jon ColemanInsiderSell22,000$56.82$1,250,040.00View SEC Filing  
8/4/2016Paul JansenEVPSell10,000$58.88$588,800.00View SEC Filing  
8/3/2016Sanford FitchDirectorSell2,000$52.62$105,240.00View SEC Filing  
7/20/2016Rick FishelInsiderSell22,000$53.85$1,184,700.00View SEC Filing  
7/20/2016Sanford FitchDirectorSell3,000$53.48$160,440.00View SEC Filing  
6/30/2016Ramshorst David J VanCAOSell5,000$52.50$262,500.00View SEC Filing  
6/7/2016Joe E KianiCEOSell65,048$50.00$3,252,400.00View SEC Filing  
6/3/2016Joe E KianiCEOSell234,952$50.09$11,768,745.68View SEC Filing  
6/1/2016Jon ColemanInsiderSell4,000$50.00$200,000.00View SEC Filing  
5/31/2016Raad Mark DeCFOSell40,000$49.43$1,977,200.00View SEC Filing  
5/25/2016Rick FishelInsiderSell25,000$49.85$1,246,250.00View SEC Filing  
5/5/2016Jon ColemanInsiderSell8,000$47.00$376,000.00View SEC Filing  
4/28/2016Paul JansenEVPSell10,000$44.88$448,800.00View SEC Filing  
4/27/2016Jon ColemanInsiderSell4,000$44.00$176,000.00View SEC Filing  
3/23/2016Yongsam LeeEVPSell96,000$39.96$3,836,160.00View SEC Filing  
3/22/2016Yongsam LeeEVPSell32,000$40.06$1,281,920.00View SEC Filing  
3/21/2016Yongsam LeeEVPSell32,000$39.83$1,274,560.00View SEC Filing  
3/15/2016Raad Mark DeCFOSell40,000$39.00$1,560,000.00View SEC Filing  
2/29/2016Raad Mark DeCFOSell40,000$38.11$1,524,400.00View SEC Filing  
12/24/2015Jon ColemaninsiderSell10,000$42.00$420,000.00View SEC Filing  
12/9/2015Sanford FitchDirectorSell2,000$41.00$82,000.00View SEC Filing  
11/11/2015Sanford FitchDirectorSell2,000$42.67$85,340.00View SEC Filing  
11/6/2015Anand SampathCOOSell45,000$42.00$1,890,000.00View SEC Filing  
11/6/2015Jon ColemaninsiderSell10,000$42.38$423,800.00View SEC Filing  
10/14/2015Sanford FitchDirectorSell2,000$39.29$78,580.00View SEC Filing  
9/17/2015Paul JansenEVPSell10,000$42.88$428,800.00View SEC Filing  
9/9/2015Sanford FitchDirectorSell2,000$41.29$82,580.00View SEC Filing  
8/31/2015Thomas Samuel McclenahanEVPSell22,000$40.62$893,640.00View SEC Filing  
8/26/2015Paul JansenEVPSell10,000$40.88$408,800.00View SEC Filing  
7/22/2015Rick FishelInsiderSell35,084$41.85$1,468,265.40View SEC Filing  
7/21/2015Joe E KianiCEOSell300,000$40.55$12,165,000.00View SEC Filing  
7/21/2015Steven BarkerDirectorSell20,000$40.00$800,000.00View SEC Filing  
7/8/2015Sanford FitchDirectorSell2,000$38.18$76,360.00View SEC Filing  
6/10/2015Sanford FitchDirectorSell2,000$36.49$72,980.00View SEC Filing  
6/4/2015Steven BarkerDirectorSell25,000$36.20$905,000.00View SEC Filing  
4/8/2015Sanford FitchDirectorSell2,000$34.57$69,140.00View SEC Filing  
2/18/2015Rick FishelInsiderSell18,170$29.85$542,374.50View SEC Filing  
5/22/2013Robert ColemanDirectorSell59,400$21.93$1,302,642.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Masimo Corporation (NASDAQ:MASI)
Latest Headlines for Masimo Corporation (NASDAQ:MASI)
Source:
DateHeadline
prnewswire.com logoMedical Equipment Stocks on Investors' Radar -- Align Technology, Masimo, Corindus Vascular Robotics, and Avinger - PR Newswire (press release)
www.prnewswire.com - September 21 at 5:37 PM
finance.yahoo.com logoRepublicans Take Last Shot at Obamacare: 5 MedTech Stocks to Buy - Yahoo News
finance.yahoo.com - September 21 at 5:37 PM
americanbankingnews.com logoMasimo Corporation (MASI) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - September 20 at 4:44 AM
streetinsider.com logoMasimo Corp. (MASI) Reports FDA Clearance and Full Market Release of Rad-97 Pulse CO-Oximeter
www.streetinsider.com - September 19 at 1:36 AM
americanbankingnews.com logoMasimo Corporation (MASI) Expected to Announce Quarterly Sales of $188.62 Million
www.americanbankingnews.com - September 19 at 1:16 AM
streetinsider.com logoMasimo Corp. (MASI) Reports FDA Clearance and Full Market ... - StreetInsider.com
www.streetinsider.com - September 18 at 8:13 PM
finance.yahoo.com logoMasimo Announces FDA Clearance and Full Market Release of Rad-97™ Pulse CO-Oximeter®
finance.yahoo.com - September 18 at 8:13 PM
finance.yahoo.com logo​Masimo gets FDA clearance for its patient monitoring system
finance.yahoo.com - September 18 at 8:13 PM
americanbankingnews.com logoMasimo Corporation (MASI) Expected to Announce Earnings of $0.53 Per Share
www.americanbankingnews.com - September 17 at 10:30 PM
finance.yahoo.com logoNewborn Foundation and Masimo Partnership Reaches 52,000 Babies and 1,000 Health Workers through Newborn Screening Initiative in Support of Every Woman Every Child
finance.yahoo.com - September 15 at 6:18 AM
fool.com logoMasimo Corporation Fell 12.7% in August -- but Why?
www.fool.com - September 11 at 6:07 PM
nasdaq.com logoWhy Is Masimo (MASI) Down 1.5% Since the Last Earnings Report? - Nasdaq
www.nasdaq.com - September 8 at 2:56 AM
finance.yahoo.com logoWhy Is Masimo (MASI) Down 1.5% Since the Last Earnings Report?
finance.yahoo.com - September 7 at 12:56 AM
finance.yahoo.com logoMasimo to Present at 15th Annual Morgan Stanley Global Healthcare Conference
finance.yahoo.com - September 7 at 12:56 AM
nasdaq.com logoRide Out MedTech Volatility With These 3 Ultra-Safe Stocks - Nasdaq
www.nasdaq.com - September 5 at 9:26 PM
finance.yahoo.com logoStudy Evaluates Performance of Masimo iSpO2® Rx Smart Device-Paired Pulse Oximeter in Screening Newborns for Critical Congenital Heart Disease
finance.yahoo.com - September 5 at 5:25 AM
americanbankingnews.com logo$188.62 Million in Sales Expected for Masimo Corporation (MASI) This Quarter
www.americanbankingnews.com - September 1 at 6:04 AM
nasdaq.com logoMasimo Breaks Above 200-Day Moving Average - Bullish for MASI ... - Nasdaq
www.nasdaq.com - September 1 at 3:30 AM
finanznachrichten.de logoStudy Evaluates Utility of Masimo SpHb During High-Blood-Loss Oncosurgery
www.finanznachrichten.de - August 28 at 5:32 AM
finance.yahoo.com logoStudy Evaluates Utility of Masimo SpHb® During High-Blood-Loss Oncosurgery
finance.yahoo.com - August 28 at 5:32 AM
zacks.com logoHere's Why Masimo (MASI) is a Suitable Value Pick for Now
www.zacks.com - August 26 at 7:52 PM
reuters.com logoBRIEF-Masimo says CFO Mark De Raad to retire ‍
www.reuters.com - August 26 at 6:56 AM
americanbankingnews.com logoMasimo Corporation (MASI) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - August 26 at 4:34 AM
reuters.com logoBRIEF-Masimo says CFO Mark De Raad to retire ​ - Reuters
www.reuters.com - August 25 at 8:10 AM
nasdaq.com logoHere's Why Masimo (MASI) is a Suitable Value Pick for Now - Nasdaq
www.nasdaq.com - August 25 at 8:10 AM
americanbankingnews.com logoMasimo Corporation (MASI) vs. Entellus Medical (ENTL) Head to Head Survey
www.americanbankingnews.com - August 22 at 2:22 PM
finanznachrichten.de logoStudy Investigates Performance of Masimo PVi As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery
www.finanznachrichten.de - August 21 at 7:46 PM
americanbankingnews.com logoSanford Fitch Sells 11,000 Shares of Masimo Corporation (MASI) Stock
www.americanbankingnews.com - August 21 at 7:26 PM
finance.yahoo.com logoStudy Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery
finance.yahoo.com - August 21 at 8:14 AM
americanbankingnews.com logoReviewing Masimo Corporation (MASI) and Entellus Medical (ENTL)
www.americanbankingnews.com - August 18 at 4:22 PM
finance.yahoo.com logoMasimo Corp. – Value Analysis (NASDAQ:MASI) : August 17, 2017
finance.yahoo.com - August 17 at 1:44 AM
finance.yahoo.com logoDubai Health Authority Implements Masimo Patient SafetyNet™
finance.yahoo.com - August 14 at 12:04 AM
americanbankingnews.com logoFinancial Review: Entellus Medical (ENTL) and Masimo Corporation (NASDAQ:MASI)
www.americanbankingnews.com - August 13 at 9:00 AM
seekingalpha.com logoMASI Beat Estimates, Then Dropped Like A Rock
seekingalpha.com - August 12 at 3:59 AM
americanbankingnews.com logoMasimo Corporation (MASI) & Entellus Medical (ENTL) Financial Comparison
www.americanbankingnews.com - August 12 at 12:30 AM
nasdaq.com logoMasimo (MASI) Shares Cross Below 200 DMA
www.nasdaq.com - August 11 at 6:22 AM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Masimo Corp.
finance.yahoo.com - August 10 at 4:32 AM
americanbankingnews.com logoWedbush Weighs in on Masimo Corporation's Q3 2017 Earnings (MASI)
www.americanbankingnews.com - August 7 at 7:40 AM
finance.yahoo.com logoStudy Evaluates Performance of Masimo SpHb® in Trauma Patients with Low Hemoglobin Levels
finance.yahoo.com - August 7 at 5:03 AM
fool.com logoDown 9.8%: Is Masimo Corporation Stock a Contrarian Buy? - Motley Fool
www.fool.com - August 5 at 2:26 AM
finance.yahoo.com logoMasimo Corp. breached its 50 day moving average in a Bearish Manner : MASI-US : August 4, 2017
finance.yahoo.com - August 5 at 2:26 AM
finance.yahoo.com logoEdited Transcript of MASI earnings conference call or presentation 2-Aug-17 8:30pm GMT
finance.yahoo.com - August 5 at 2:26 AM
americanbankingnews.com logoMasimo Corporation to Post FY2017 Earnings of $2.80 Per Share, William Blair Forecasts (MASI)
www.americanbankingnews.com - August 4 at 10:46 AM
americanbankingnews.com logoMasimo Corporation Expected to Post FY2017 Earnings of $2.80 Per Share (NASDAQ:MASI)
www.americanbankingnews.com - August 4 at 10:46 AM
fool.com logoDown 9.8%: Is Masimo Corporation Stock a Contrarian Buy?
www.fool.com - August 4 at 9:20 AM
fool.com logoMasimo Corporation Raises Full-Year Guidance After Second-Quarter Earnings Soar - Motley Fool
www.fool.com - August 4 at 1:13 AM
americanbankingnews.com logoMasimo Corporation (NASDAQ:MASI) Earns Buy Rating from Stifel Nicolaus
www.americanbankingnews.com - August 3 at 10:28 PM
fool.com logoMasimo Corporation Raises Full-Year Guidance After Second-Quarter Earnings Soar
www.fool.com - August 3 at 10:03 AM
finance.yahoo.com logoMasimo Reports Second Quarter 2017 Financial Results
finance.yahoo.com - August 3 at 4:14 AM
finance.yahoo.com logoMasimo beats Street 2Q forecasts
finance.yahoo.com - August 3 at 4:14 AM

Social

Chart

Masimo Corporation (MASI) Chart for Friday, September, 22, 2017

This page was last updated on 9/22/2017 by MarketBeat.com Staff